Centro médico Anadolu
El costo total del tratamiento de meningioma en Turquía varía según el plan de tratamiento específico y los procedimientos requeridos. Por ejemplo, una consulta con un neurocirujano cuesta aproximadamente 132 €, mientras que un procedimiento que involucra resección tumoral con neuronavegación y aspirador ultrasónico tiene un precio de 17.890 €. Procedimientos adicionales como el tratamiento con Gamma Knife comienzan en 6.580 €. El plan de tratamiento se finaliza después de una evaluación exhaustiva por parte de profesionales médicos, asegurando un enfoque personalizado para cada paciente.
| España | Turquía | México | |
| TrueBeam | de $12,000 | de $3,500 | de $9,000 |
| Radioterapia para el cáncer colorrectal | de $10,000 | de $7,000 | de $6,000 |
| Gamma Knife | de $18,000 | de $6,300 | de $35,000 |
| Eliminación de meningioma | de $30,000 | de $21,900 | de $20,000 |
| CyberKnife | de $30,000 | de $4,750 | de $30,000 |
La Dra. Eda Tanrikulu se especializa en oncología médica y quimioterapia en el Centro Médico Anadolu, centrándose en casos complejos de cáncer.
El Dr. Solak completó una prestigiosa beca de especialización en el Instituto del Cáncer de la Universidad de Hacettepe, especializándose en casos oncológicos complejos.
El Prof. Dr. Ahmet Hilmi Kaya es profesor de neurocirugía en el Centro Médico Anadolu, en Gebze (Turquía). Obtuvo el título de médico (MD) en la Universidad de Estambul, Cerrahpaşa (programa en inglés), donde realizó la residencia en neurocirugía entre 1996 y 2003. Fue nombrado profesor en 2015. Realizó estancias de observación en la Universidad de Maastricht en 2007 y 2009.
Su actividad clínica abarca la neurocirugía funcional y estereotáxica, incluida la estimulación cerebral profunda (DBS) para la enfermedad de Parkinson y el temblor esencial. También trata tumores de la columna y estenosis espinal, y realiza instrumentación de columna. Atiende tumores de base de cráneo y cerebrales. Realiza cirugía vascular del sistema nervioso central.
Entre sus logros figuran la dirección de un proyecto de investigación sobre Parkinson en la Universidad Ondokuz Mayıs (BAP, proyecto n.º T.597, 2008) y la supervisión de una tesis de neurocirugía en 2008. Sus galardones incluyen el tercer puesto en el 2.º Congreso Nacional de la Sociedad de Neurocirugía (2006), la beca en el extranjero de la Sociedad Turca de Neurocirugía (2008) y el Premio Aysima Altınok a la Tesis (2009). Varios de sus trabajos fueron destacados en los 22.º y 23.º Congresos Científicos de la Sociedad Turca de Neurocirugía (2008 y 2009). Es miembro de la Sociedad Turca de Neurocirugía y de la Asociación Médica Turca.
La Dra. Banu Atalar es oncóloga radioterápica con certificación de especialidad (Turquía, 2004). Es catedrática en la Universidad Acibadem MAA (2018–presente) y médica en Anadolu Medical Center (2026–presente). Se formó en Estambul y en Cerrahpaşa. En 2011 completó una beca de investigación clínica en Stanford en radiocirugía estereotáctica. Su práctica se centra en tumores del SNC, torácicos y gastrointestinales. Aproximadamente el 75% de su actividad clínica implica SRS y SRS adaptativa guiada por RM.
Entre sus distinciones figuran el premio IDEA de ASCO (2004), el International Mentorship Award de la IASLC (2018) y la distinción H.FACR (2025). Cuenta con 72 publicaciones internacionales revisadas por pares. Sus cargos de liderazgo incluyen presidenta de la Sociedad Turca de Oncología Radioterápica (2025–27) y presidenta del Comité de Sociedades Nacionales de ESTRO (2024–27). Formó parte del Comité de Guías Estratificadas por Recursos de ASCO (2013–18) y de los comités de programa y de nominaciones de la RSS. Organizó congresos nacionales (2023, 2025) y ha sido ponente invitada en reuniones de primer nivel.
Surgery is not always required for a meningioma. Doctors often recommend observation for small, slow-growing tumors. Non-invasive alternatives like Gamma Knife or CyberKnife treat tumors in tricky locations. Surgical intervention is usually reserved for large or aggressive Grade 2 and 3 tumors causing symptoms.
Bookimed Expert Insight: Turkish neurosurgery centers like Anadolu Medical Center often offer CyberKnife for cases that other clinics might label inoperable. Over 40% of cases we see are managed without open surgery. This trend favors patients with tumors near delicate optic nerves or the brainstem. CyberKnife often preserves functions better than invasive resection in these sensitive areas.
Patient Consensus: Patients initially worried about brain surgery often find relief after learning about non-invasive options. Many note that simple monitoring is enough for years if the tumor stays stable.
Primary treatment for meningioma in Turkey includes microsurgical resection and precision radiation therapy. Surgeons use neuronavigation and intraoperative MRI for accurate tumor removal. Non-invasive options like Gamma Knife and CyberKnife target inoperable tumors. Many Turkish neurosurgery centers hold JCI accreditation for safety.
Bookimed Expert Insight: Anadolu Medical Center stands out because of its affiliation with Johns Hopkins. This partnership brings US-level oncology protocols to the region. The center offers specialized CyberKnife and Gamma Knife technologies. These systems allow doctors to treat complex cases without traditional open surgery.
Patient Consensus: Patients note it is important to choose clinics offering robotic systems. Many appreciate the detailed pre-surgery maps that help protect speech and movement.
Neurosurgeons in Turkey report success rates exceeding 90% for meningioma removal procedures. Specialized centers maintain a 91% success rate for intracranial neurosurgeries using advanced neuronavigation. Benign tumor control typically reaches 95%. Grade I early-stage cases show long-term remission in 85% of patients.
Bookimed Expert Insight: Success often depends on specific equipment availability rather than just surgeon skill. Centers like Memorial Hospital and Liv Hospital prioritize hybrid operating rooms. These rooms allow for immediate post-operative scans while the patient is still sedated. This technology helps surgeons confirm total tumor resection before finishing the procedure. This approach significantly reduces the need for secondary revision surgeries.
Patient Consensus: Patients often mention feeling reassured by the thoroughness of pre-surgical neurological testing. Many note the high level of personal care from nursing staff during recovery.
Most patients stay in the hospital for 3 to 7 days after meningioma surgery. The total recovery period to return to work usually takes 6 to 12 weeks. Specialized centers in Turkey prioritize early mobilization to improve outcomes and speed up discharge.
Bookimed Expert Insight: Turkish oncology centers often use neuro-navigation and neuromonitoring during meningioma removal. These technologies help preserve healthy brain tissue. Our data shows this precision often reduces ICU stays to just 24 hours. Shorter ICU stays help patients begin physical therapy much faster.
Patient Consensus: Patients emphasize that extreme fatigue is normal during the first month home. Many suggest having a caregiver ready for at least 2 weeks after discharge.
Anadolu Medical Center and Memorial Bahcelievler Hospital are Turkey's top JCI-accredited facilities for meningioma. These centers employ board-certified neurosurgeons who specialize in skull-base tumors. Treatment plans utilize advanced systems like Gamma Knife, CyberKnife, and neuronavigation to ensure high precision.
Bookimed Expert Insight: Our clinic data highlights Dr. Serdar Kahraman at Anadolu Medical Center. He brings 35+ years of experience in complex brain surgeries. Anadolu serves a high volume of international patients each year. This clinical depth ensures safe handling of tumors near the optic nerve. Many clinics offer similar technology but few possess this surgical volume.
Patient Consensus: Patients emphasize that receiving a detailed treatment plan before traveling reduces anxiety. They frequently mention the professionalism of neurosurgery teams and the comfort of modern facilities.
Meningiomas can recur even after successful treatment. Grade 1 tumors show a 50% recurrence over 20 years. Grade 2 and 3 tumors return more frequently. Lifelong follow-up with contrast-enhanced MRI is essential. This monitors the site for any regrowth or new tumor tissue.
Bookimed Expert Insight: Turkish neurosurgery centers often integrate Intraoperative MRI (iMRI) during the initial resection. This technology helps surgeons confirm total removal before closing the skull. Our data shows this precision significantly reduces the need for secondary radiation later. This proactive approach helps keep long-term recurrence rates lower for patients.
Patient Consensus: Patients emphasize the relief of having a clear long-term scanning schedule. They note that staying consistent with follow-up appointments provides peace of mind.